Ivermectin Ratiopharm (Ivermectin)

Ivermectin acts by binding to glutamate‑gated chloride channels in the nerve and muscle cells of invertebrate parasites. This binding opens the channels, allowing an influx of chloride ions, which hyperpolarizes the cell membrane, leading to paralysis and death of the parasite. Human cells lack these specific channels, which limits toxicity.

The appropriate dose of Ivermectin Ratiopharm is determined by the prescribing clinician based on the specific infection, patient weight, age, and overall health status. Dosage regimens can vary between indications, and the prescriber follows current clinical guidelines and product labeling to set the exact amount.

Safety data for ivermectin in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians must evaluate each case individually and discuss potential risks with the patient before prescribing.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Ivermectin Ratiopharm. GNH India supplies hospitals, pharmacies, and procurement teams worldwide. After the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details, and any necessary import documentation.

Ivermectin is a broad‑spectrum anthelmintic with a unique mechanism targeting glutamate‑gated chloride channels, which differs from drugs like albendazole that inhibit microtubule formation. It is often preferred for infections such as onchocerciasis and scabies due to its efficacy and convenient single‑dose regimen, while other agents may be chosen based on parasite type or resistance patterns.

Ivermectin Ratiopharm should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original packaging to protect them from moisture, light, and excessive heat. Do not store in the refrigerator or freezer, as this could affect product stability.

The medication is taken orally, usually as a single tablet or as directed by the prescriber. It should be swallowed with water on an empty stomach unless the product label specifies otherwise. The exact administration schedule depends on the diagnosed condition and the clinician’s instructions.

Serious adverse events, although rare, can include severe hypersensitivity reactions such as anaphylaxis, neurological complications like seizures or ataxia, and liver injury indicated by elevated enzymes. Patients should be monitored for any unusual symptoms, and immediate medical attention is required if severe reactions occur.

Ivermectin should be avoided in individuals with known hypersensitivity to the drug, those with severe liver impairment, and patients taking medications that strongly induce CYP3A4 or inhibit P‑glycoprotein without medical supervision. Pregnant or breastfeeding women should only use it when the potential benefits clearly outweigh the risks.